Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Nature Biotechnology|August 16, 2011
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsChad Tang, Andrew S Lee, Jens-Peter Volkmer, et al.
Plos One|May 2, 2024
Development and evaluation of a usable blastocyst predictive model using the biomechanical properties of human oocytesDaniel Meyer, Jonathan Kort, Ching Hung Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitmentPratik Home, Biswarup Saha, Soma Ray, et al.
F&S Reports|March 25, 2024
The first clinical validation of whole-genome screening on standard trophectoderm biopsies of preimplantation embryosYuntao Xia, Maria Katz, Dhruva Chandramohan, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.
ESMO Open|October 24, 2020
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignanciesAparna Hegde, Alexander Y Andreev-Drakhlin, Jason Roszik, et al.
Cell|May 7, 2026
Disrupted molecular glue complex drives RAS inhibitor resistanceBen Sang, Ling Feng Ye, Zheng Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid MalignanciesAparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung CancerDaniel Morgensztern, Neal Ready, Melissa L Johnson, et al.
Pageof 14